Clinical Trial Update: PI or NNRTI as First-line Treatment of HIV in West Africa - the PIONA Trial [Phase 4]

View source ↗

Summary

The PIONA trial evaluated first-line HIV treatment using a protease inhibitor (PI) or an NNRTI in West Africa. The study is reported as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Non-nucleoside reverse transcriptase inhibitor (NNRTI) (non-nucleoside reverse transcriptase inhibitor)
• Protease inhibitor (PI) (protease inhibitor)

Snippet

Sponsor: University of Aarhus | Conditions: HIV-1 | Phase 4 | Status: COMPLETED